Cite
CTNI-61. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA
MLA
Abed Rahman Kawakibi, et al. “Ctni-61. Clinical Efficacy and Predictive Biomarkers of Onc201 in H3k27m-Mutant Diffuse Midline Glioma.” Neuro-Oncology, vol. 24, Nov. 2022, pp. vii86-vii87. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........036ba8c3615a5a91df3fc469db7f43ac&authtype=sso&custid=ns315887.
APA
Abed Rahman Kawakibi, Rohinton Tarapore, Sharon Gardner, Andrew Chi, Sylvia Kurz, Patrick Y Wen, Isabel Arrillaga-Romany, Tracy Batchelor, Nicholas Butowski, Ashley Sumrall, Nicole Shonka, Rebecca Harrison, John DeGroot, Minesh Mehta, Yazmin Odia, Matthew Hall, Doured Daghistani, Timothy Cloughesy, Benjamin Ellingson, … Carl Koschmann. (2022). Ctni-61. Clinical Efficacy and Predictive Biomarkers of Onc201 in H3k27m-Mutant Diffuse Midline Glioma. Neuro-Oncology, 24, vii86-vii87.
Chicago
Abed Rahman Kawakibi, Rohinton Tarapore, Sharon Gardner, Andrew Chi, Sylvia Kurz, Patrick Y Wen, Isabel Arrillaga-Romany, et al. 2022. “Ctni-61. Clinical Efficacy and Predictive Biomarkers of Onc201 in H3k27m-Mutant Diffuse Midline Glioma.” Neuro-Oncology 24 (November): vii86-vii87. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........036ba8c3615a5a91df3fc469db7f43ac&authtype=sso&custid=ns315887.